Clinical Trial

REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The Study is an observational, retrospective study which aim is to assess cenobamate's healthcare resources utilization (HCRU) in the management of uncontrolled focal onset seizures. The amin objective is to compare the resource utilization before and after the use of cenobamate. Data from medical charts will be used and inserted into the eCRF from which the analyses will be conducted. Data from 200 patients from 10 sites in 5 countries are included.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-09.
Trial Details
NCT Number NCT06922175
Lead Sponsor Aziende Chimiche Riunite Angelini Francesco S.p.A
Collaborators: 1Med
Conditions Epilepsy With Uncontrolled Focal-onset Seizures
Enrollment 200 participants
Start Date 2024-12-19
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-02